Robert Náplava
Robert Náplava publishes mostly in Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, on topics such as Lipoproteins and Cardiovascular Health, Protease and Inhibitor Mechanisms and Atherosclerosis and Cardiovascular Diseases.
- World rank
- #2,290,824 of 7,710,434 ranked researchers
- Rank in United States
- #683,782 of 1,627,098
- Works
- 23
- Citations
- 703
- Citations per work
- 30.6
What does Robert Náplava research?
Robert Náplava's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (7%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1566.7%
- Medicine1566.7%
- Everything else521.0%
- Life Sciences312.3%
- 1Surgery25% of their works
- 2Cardiology and Cardiovascular Medicine23% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Cancer Research7% of their works
- 5Endocrinology, Diabetes and Metabolism7% of their works
- 6Immunology5% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Protease and Inhibitor Mechanisms
- Atherosclerosis and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Coronary Artery Anomalies
- Coronary Interventions and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
Which keywords describe Robert Náplava's research?
The keywords of their largest research topics: Atherosclerosis, Cholesterol-lowering, Statins, Obesity, Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, Cardiovascular Disease and Chamber Quantification.
- Perioperative
- Myocardial Revascularization
- Inflammation
- Echocardiography
- Coronary Artery Anomalies
- Chamber Quantification
- Tissue Inhibitors of Metalloproteinases
- Obesity
- Cholesterol-lowering
- Atherosclerosis
- Statins
- Matrix Metalloproteinases
- Cardiovascular Disease
- Congenital
- Coronary Stents
- Immune Response
- Metabolic Syndrome
- Cardiac Risk
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Atherosclerosis93 topics
- Cholesterol-lowering71 topic
- Statins71 topic
- Obesity62 topics
- Matrix Metalloproteinases41 topic
- Tissue Inhibitors of Metalloproteinases41 topic
- Cardiovascular Disease31 topic
- Chamber Quantification31 topic
- Congenital31 topic
- Coronary Artery Anomalies31 topic
- Coronary Stents31 topic
- Echocardiography31 topic
- Immune Response31 topic
- Inflammation31 topic
- Metabolic Syndrome31 topic
- Myocardial Revascularization31 topic
- Cardiac Risk21 topic
- Perioperative21 topic
Where does Robert Náplava work?
Robert Náplava's main affiliation in the publication record is University of Alabama at Birmingham, United States.
How many publications and citations does Robert Náplava have?
OpenAlex counts 23 works and 703 citations for Robert Náplava, an h-index of 7, ranking #2,290,824 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert Náplava. Posts are plain text and can be reported.